Health Care

CKD BiO

CKD BiO is expanding its presence to the world market by utilizing its competitive edge in the bio APIs business line.

CKD BiO was split from Chong Kun Dang in November of 2011. CKD BiO plans to expand its growth as a leading global company by high quality medicine supplies and probiotics production, continuous exports, and focused efforts on micro-biome R&D (Research & Development) based on its leading fermentation technology.

Link to CKD BiO
CKD BiO
CEO

Wan-Kap, Park
Foundation

November 12, 2001
Business Line

Manufacturing/Sales of Medicine Supplies
Paid in Capital

13,715 (million won)
Address

8, Chungjeong-ro, Seodaemun-gu, Seoul, Korea (5th Floor, CKD Building)
TEL / FAX

82-2-2194-0555 / 82-2-2194-0556